Iovance Biotherapeutics CEO Exercises 200k Stock Options, Boosting Ownership
CEO of Iovance Biotherapeutics exercises 200,000 share stock option, boosting holdings to 8,700 shares – reflecting confidence amid volatile biotech stock.
2 minutes to read

